228 related articles for article (PubMed ID: 36910075)
21. Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
Lip GYH; Collet JP; de Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B
Thromb Haemost; 2017 Dec; 117(12):2215-2236. PubMed ID: 29212110
[TBL] [Abstract][Full Text] [Related]
22. Associations of long-term exposure to traffic-related air pollution with risk of valvular heart disease based on a cross-sectional study.
Pang Y; Liu S; Yan L; Wang Q; Li L; Chu C; Ning J; Zhang B; Wang X; Ma S; Su D; Zhang R; Niu Y
Ecotoxicol Environ Saf; 2021 Feb; 209():111753. PubMed ID: 33348255
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy).
Ezekowitz MD; Nagarakanti R; Noack H; Brueckmann M; Litherland C; Jacobs M; Clemens A; Reilly PA; Connolly SJ; Yusuf S; Wallentin L
Circulation; 2016 Aug; 134(8):589-98. PubMed ID: 27496855
[TBL] [Abstract][Full Text] [Related]
24. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
[TBL] [Abstract][Full Text] [Related]
25. Prospective cohort study of characteristics and sex differences in elderly patients with degenerative valvular disease.
Qi X; Xu H; Liu Q; Ye Y; Wu Y;
BMJ Open; 2022 Aug; 12(8):e060882. PubMed ID: 35977761
[TBL] [Abstract][Full Text] [Related]
26. Arrhythmias in Patients With Valvular Heart Disease: Gaps in Knowledge and the Way Forward.
Kubala M; de Chillou C; Bohbot Y; Lancellotti P; Enriquez-Sarano M; Tribouilloy C
Front Cardiovasc Med; 2022; 9():792559. PubMed ID: 35242822
[TBL] [Abstract][Full Text] [Related]
27. Stages of Valvular Heart Disease Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.
Shelbaya K; Claggett B; Dorbala P; Skali H; Solomon SD; Matsushita K; Konety S; Mosley TH; Shah AM
Circulation; 2023 Feb; 147(8):638-649. PubMed ID: 36524478
[TBL] [Abstract][Full Text] [Related]
28. Clinical, sonographic characteristics and long-term prognosis of valvular heart disease in elderly patients.
Song F; Liu FZ; Liang YF; Tse G; Li X; Liao HT; Chen JY
J Geriatr Cardiol; 2019 Jan; 16(1):33-41. PubMed ID: 30800149
[TBL] [Abstract][Full Text] [Related]
29. Epidemiologic Profile of Patients With Valvular Heart Disease in Korea: A Nationwide Hospital-Based Registry Study.
Choi YJ; Son JW; Kim EK; Kim IC; Kim HY; Seo JS; Sun BJ; Shim CY; Yoon SJ; Lee S; Lee SH; Park JB; Kang DH
J Cardiovasc Imaging; 2023 Jan; 31(1):51-61. PubMed ID: 36693346
[TBL] [Abstract][Full Text] [Related]
30. Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey.
Tribouilloy C; Bohbot Y; Kubala M; Ruschitzka F; Popescu B; Wendler O; Laroche C; Bartha E; Ince H; Simkova I; Vahanian A; Iung B
Eur Heart J; 2022 Aug; 43(29):2756-2766. PubMed ID: 35511056
[TBL] [Abstract][Full Text] [Related]
31. Computational fluid dynamics modelling of left valvular heart diseases during atrial fibrillation.
Scarsoglio S; Saglietto A; Gaita F; Ridolfi L; Anselmino M
PeerJ; 2016; 4():e2240. PubMed ID: 27547548
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study.
Andell P; Li X; Martinsson A; Andersson C; Stagmo M; Zöller B; Sundquist K; Smith JG
Heart; 2017 Nov; 103(21):1696-1703. PubMed ID: 28432156
[TBL] [Abstract][Full Text] [Related]
33. Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study.
Vedovati MC; Reboldi G; Agnelli G; Verdecchia P;
TH Open; 2019 Apr; 3(2):e157-e164. PubMed ID: 31259298
[No Abstract] [Full Text] [Related]
34. Effects of nonvalvular atrial fibrillation on the structure and function of mitral valves (a STROBE-compliant article).
Huang DQ; Cui CY; Zhang J; Liu YY; Qin YY; Zhang LZ; Liu L
Medicine (Baltimore); 2018 Aug; 97(33):e11643. PubMed ID: 30113455
[TBL] [Abstract][Full Text] [Related]
35. Meta-Analysis Global Group in Chronic Heart Failure score for the prediction of mortality in valvular heart disease.
Lv J; Xu H; Ye Y; Li Z; Wang W; Zhang B; Zhao Q; Zhang H; Zhao Z; Liu Q; Wang B; Duan Z; Yu Z; Guo S; Zhao Y; Gao R; Ge J; Wu Y;
ESC Heart Fail; 2024 Feb; 11(1):349-365. PubMed ID: 38012105
[TBL] [Abstract][Full Text] [Related]
36. Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease.
Briasoulis A; Inampudi C; Akintoye E; Alvarez P; Panaich S; Vaughan-Sarrazin M
J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29622591
[TBL] [Abstract][Full Text] [Related]
37. Characteristics, interventions and outcomes of patients with valvular heart disease hospitalised in China: a cross-sectional study.
Huang X; Dhruva SS; Yuan X; Bai X; Lu Y; Yan X; Liu J; Li W; Hu D; Ji R; Gao M; Miao F; Li J; Ge J; Krumholz HM; Li J
BMJ Open; 2021 Nov; 11(11):e052946. PubMed ID: 34732492
[TBL] [Abstract][Full Text] [Related]
38. Atrial fibrillation in pure rheumatic mitral valvular disease is expression of an atrial histological change.
Alessandri N; Tufano F; Petrassi M; Alessandri C; Di Cristofano C; Della Rocca C; Gallo P
Eur Rev Med Pharmacol Sci; 2009; 13(6):431-42. PubMed ID: 20085124
[TBL] [Abstract][Full Text] [Related]
39. Coronary artery disease is associated with valvular heart disease, but could it Be a predictive factor?
Matta A; Moussallem N
Indian Heart J; 2019; 71(3):284-287. PubMed ID: 31543203
[TBL] [Abstract][Full Text] [Related]
40. Five-year epidemiological survey of valvular heart disease: changes in morbidity, etiological spectrum and management in a cardiovascular center of Southern China.
Liu FZ; Xue YM; Liao HT; Zhan XZ; Guo HM; Huang HL; Fang XH; Wei W; Rao F; Deng H; Liu Y; Lin WD; Wu SL
J Thorac Dis; 2014 Dec; 6(12):1724-30. PubMed ID: 25589965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
